Sermo, Bloomberg partner on service for healthcare investors
The Healthcare Exchange, demonstrated for the first time to a select audience of industry leaders last night in San Francisco, gives users direct access to the observations and insights of Sermo's 90,000-strong physician community through the Bloomberg Professional Service. With one click, 280,000-plus analysts and investors can gain instant access to what Palestrant described as “the front-lines of medicine,” giving users “actionable intelligence about therapies and devices” on which to base investing decisions—and effectively offering early intelligence of market-changing events in healthcare.
Investors and analysts will be able to pose questions to physicians to gauge opinion and reactions to potentially market-changing information, such as company statements about the efficacy of therapies or media stories about adverse events.
Palestrant told the invitation-only audience that the Healthcare Exchange will “tear down” barriers to information. “For physicians, this provides a voice beyond the bound of their community,” he said. “For investors, it is a disruptive technology that leads to more transparent information and better investment decisions.”
The new service will become a feature of the Bloomberg function BDRUG, which provides daily-updated information on every drug marketed in the US, from clinical trials results to prescription data, and will be available as part of the Bloomberg Professional service.